Ruba Ismail

693 total citations
16 papers, 534 citations indexed

About

Ruba Ismail is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Ruba Ismail has authored 16 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmaceutical Science, 7 papers in Molecular Biology and 6 papers in Biomaterials. Recurrent topics in Ruba Ismail's work include Advanced Drug Delivery Systems (13 papers), Drug Solubulity and Delivery Systems (7 papers) and Nanoparticle-Based Drug Delivery (5 papers). Ruba Ismail is often cited by papers focused on Advanced Drug Delivery Systems (13 papers), Drug Solubulity and Delivery Systems (7 papers) and Nanoparticle-Based Drug Delivery (5 papers). Ruba Ismail collaborates with scholars based in Hungary, Austria and Vietnam. Ruba Ismail's co-authors include Ildikó Csóka, Fakhara Sabir, Gábor Katona, Rita Ambrus, Flavia Laffleur, Andreas Bernkop‐Schnürch, Edina Pallagi, Alexandra Bocsik, Ilona Gróf and Mária A. Deli and has published in prestigious journals such as International Journal of Pharmaceutics, Pharmaceutical Research and Drug Discovery Today.

In The Last Decade

Ruba Ismail

16 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruba Ismail Hungary	11	296	237	102	66	61	16	534
Yulian Lin China	12	210 0.7×	347 1.5×	66 0.6×	18 0.3×	22 0.4×	18	673
Dongqin Quan China	16	160 0.5×	211 0.9×	108 1.1×	16 0.2×	107 1.8×	36	600
Fiona McCartney Ireland	13	349 1.2×	207 0.9×	80 0.8×	28 0.4×	31 0.5×	22	561
Ritu Karwasra India	14	127 0.4×	175 0.7×	102 1.0×	19 0.3×	85 1.4×	43	567
Lingbing Li China	9	98 0.3×	124 0.5×	177 1.7×	24 0.4×	63 1.0×	15	440
J.D. Pipkin United States	16	209 0.7×	175 0.7×	39 0.4×	47 0.7×	40 0.7×	34	529
Iti Chauhan India	8	363 1.2×	193 0.8×	119 1.2×	18 0.3×	46 0.8×	35	613
Akshay Vyawahare India	11	74 0.3×	174 0.7×	130 1.3×	12 0.2×	83 1.4×	17	552
Manman Li China	11	94 0.3×	172 0.7×	90 0.9×	20 0.3×	45 0.7×	33	439
Yongmei Hao China	6	238 0.8×	127 0.5×	31 0.3×	12 0.2×	16 0.3×	13	446

Countries citing papers authored by Ruba Ismail

Since Specialization

Citations

This map shows the geographic impact of Ruba Ismail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruba Ismail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruba Ismail more than expected).

Fields of papers citing papers by Ruba Ismail

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruba Ismail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruba Ismail. The network helps show where Ruba Ismail may publish in the future.

Co-authorship network of co-authors of Ruba Ismail

This figure shows the co-authorship network connecting the top 25 collaborators of Ruba Ismail. A scholar is included among the top collaborators of Ruba Ismail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruba Ismail. Ruba Ismail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Ismail, Ruba, et al.. (2023). Application of biorelevant in vitro assays for the assessment and optimization of ASD-based formulations for pediatric patients. European Journal of Pharmaceutics and Biopharmaceutics. 185. 13–27. 5 indexed citations

Ismail, Ruba, et al.. (2021). A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation. International Journal of Pharmaceutics. 604. 120724–120724. 47 indexed citations

Ismail, Ruba, et al.. (2021). Regulatory status quo and prospects for biosurfactants in pharmaceutical applications. Drug Discovery Today. 26(8). 1929–1935. 32 indexed citations

Sabir, Fakhara, Gábor Katona, Ruba Ismail, et al.. (2021). Development and Characterization of n-Propyl Gallate Encapsulated Solid Lipid Nanoparticles-Loaded Hydrogel for Intranasal Delivery. Pharmaceuticals. 14(7). 696–696. 23 indexed citations

Sabir, Fakhara, Ruba Ismail, Gábor Katona, & Ildikó Csóka. (2021). Nose to brain delivery of n-propylgallte loaded lipid nanoparticles for targeting glioblastoma multiforme via QbD approach. 50–50. 1 indexed citations

Ismail, Ruba, et al.. (2020). Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery. European Journal of Pharmaceutics and Biopharmaceutics. 152. 10–17. 36 indexed citations

Ismail, Ruba, et al.. (2020). Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer’s disease. European Journal of Pharmaceutics and Biopharmaceutics. 148. 38–53. 74 indexed citations

Sabir, Fakhara, Gábor Katona, Ruba Ismail, & Ildikó Csóka. (2020). Development and Optimization of n-Propyl Gallate-Encapsulated Hyaluronic Acid-Based Hydrogel for Nose-to-Brain Delivery Applying Quality-by-Design Methodology. MDPI (MDPI AG). 46–46. 1 indexed citations

Ismail, Ruba, et al.. (2020). The Effect of Counterions in Hydrophobic Ion Pairs on Oral Bioavailability of Exenatide. ACS Biomaterials Science & Engineering. 6(9). 5032–5039. 31 indexed citations

10.

Sabir, Fakhara, Ruba Ismail, & Ildikó Csóka. (2019). Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook. Drug Discovery Today. 25(1). 185–194. 69 indexed citations

11.

Ismail, Ruba, Tamás Sovány, Attila Gácsi, et al.. (2019). Synthesis and Statistical Optimization of Poly (Lactic-Co-Glycolic Acid) Nanoparticles Encapsulating GLP1 Analog Designed for Oral Delivery. Pharmaceutical Research. 36(7). 99–99. 42 indexed citations

12.

Ismail, Ruba, Alexandra Bocsik, Gábor Katona, et al.. (2019). Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability. Pharmaceutics. 11(11). 599–599. 41 indexed citations

13.

Pallagi, Edina, et al.. (2018). Initial Risk Assessment as part of the Quality by Design in peptide drug containing formulation development. European Journal of Pharmaceutical Sciences. 122. 160–169. 34 indexed citations

14.

Ismail, Ruba & Ildikó Csóka. (2017). Up to date advances in nano-carrier systems for oral delivery of antidiabetic peptides. Journal of Nanomedicine & Nanotechnology. 2 indexed citations

15.

Ismail, Ruba & Ildikó Csóka. (2017). Novel strategies in the oral delivery of antidiabetic peptide drugs – Insulin, GLP 1 and its analogs. European Journal of Pharmaceutics and Biopharmaceutics. 115. 257–267. 94 indexed citations

16.

Ismail, Ruba, et al.. (2015). Formulation andin vitroevaluation of once-daily methyldopa sustained release matrix tablets. Research Journal of Pharmacy and Technology. 8(2). 161–161. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact